Exxaro Tiles Ltd – Globe Capital
Exxaro Tiles Ltd
Closed
Price Band
Rs. 118 – 120
IPO Issue Period
Aug 04, 2021 to Aug 06, 2021
Issue Size
Rs. 161.09 Cr.
Face value
Rs. 10/-
Fresh issue
Rs. 134.23 Cr.
Offer for sale
Rs. 26.86 Cr.
Minimum Shares for Retail
125 shares
Maximum Shares for Retail
1625 shares
Listing on
NSE, BSE
Issue Type
Book Building
Tentative Listing Date
17-Aug-21
QIB
Not More than 25% of the offer
NII
Not less than 35% of the offer
Retail
Not less than 40% of the offer
Registrar to the Issue
Link Intime India Private Ltd

Pantomath Capital Advisors Pvt Ltd

Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients. Rajendra Mutha is the promoter of the company.

For year/ period ended ( in Cr.)

31 Mar 2021 31 Mar 2020 31 Mar 2019
Total Revenue 259.85 243.96 244
Profit After Tax 15.22 11.25 8.91
EPS 4.5 3.6 2.7
OPM(%) 18.6% 17.8% 15.6%
PATM(%) 6.00% 5.1% 3.70%
  • The Company has large dealer network with 2,000+ registered dealers.
  • Strong PAN India presence in 27 states of India.
  • International presence with export to 13+ countries across the globe.
  • One of the largest manufacturing plants of glazed vitrified tiles in India.
  • To make repayment or prepayment of secured borrowings availed by the company.
  • To meet working capital requirements.
  • Meet general corporate purposes.

The company is in the highly competitive field having fragmented players. Based on super earnings of FY21, the issue is valued at a P/E of 35 plus. Being IPO under Rs. 250 cr., the Company will list in T2T (Trade to Trade) category this may restrict speculative moves.

Open Account